TNF and inflammatory bowel disease: While the presence of comorbidities did not increase the risk of malignancies with anti-TNF use, the presence of cardiovascular disease was independently associated with the occurrence of serious infections (80) and no differences in the clinical effectiveness of anti-TNFs between patients with and without comorbidity with IBD were reported.